The company was last valued at $592.4M in March 2021. Here are the top-line bullets you need to know.
Viz.ai, an AI-backed diagnostic imaging platform, has raised $100M in a Series D that drew participation from CRV, Google Ventures, Insight Partners, and Tiger Global Management, among others.
HOW’S THE COMPANY PERFORMING?
- California-based Viz.ai leverages AI and machine learning to accelerate disease detection and coordinate care accordingly.
- The company serves millions of patients across 1K+ hospitals in the US and EMEA.
- Its customers include Thomas Jefferson University, Banner Health, Mount Sinai Health System, CommonSpirit Health, and HCA Healthcare.
- Its employee base grew from 180 to 350 in 2021, and the company plans to add around 200 more employees over the next year.
- It has offices across San Francisco, Tel Aviv, Amsterdam, and Portugal.
Source: Viz.ai
WHY DOES THE MARKET MATTER?
- The global artificial intelligence in diagnostics market is expected to reach a value of $5.5B by 2030, growing at a CAGR of 26.3%, according to Grand View Research.
- Healthcare AI funding hit $12.2B in 2021, nearly double 2020’s total.
- The rising prevalence of chronic disease alongside care provider shortages has contributed to market growth.
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.